RSV antibody shot nirsevimab gets FDA approval to protect infants from virus

Sanofi's RSV antibody shot, nirsevimab, got FDA approval to protect infants on Monday.

Related Keywords

Ohio ,United States ,Cleveland Clinic ,Florida ,Petersburg ,Sankt Peterburg ,Russia ,Chicago ,Illinois ,New York ,American ,John Farley ,Cheryl Meany ,Michael Greenberg ,Rachel Dawkins ,Frank Esper ,Pfizer ,Drug Administration ,Office Of Infectious Diseases ,Centers For Disease ,Advisory Committee On Immunization Practices ,Cnn ,Infectious Diseases ,Drug Evaluation ,Disease Control ,Advisory Committee ,Immunization Practices ,Johns Hopkins All Children ,North American ,Fda Rsv ,Rsv ,Beyfortus ,Nirsevimab ,Anofi Rsv ,Rsv Shot ,Sv Baby ,Rsv Virus ,Rsv In Babies ,Rsv Treatment ,Sv Antibody ,Ntibody ,Irsevimab Fda Approval ,Fda Approved ,Fda Approves ,